Analyst Ratings for ADC Therapeutics (ADCT)
ADCT Rating Summary
ADCT Price Target Summary
- Highest: $10.00 (Guggenheim)
- Lowest: $2.00 (RBC Capital)
- Average: $7.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$7.00 (+542.2%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 46%
Avg. $ Target:
$7.00 (+542.2%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 46%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/8/2026 | H.C. Wainwright | Robert Burns | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.03 (1.09) |
5.83% | Details |
| 6/4/2026 | RBC Capital | Leonid Timashev | Downgrade | Sector Perform (Outperform) |
2.00 (6.00) |
3.17 (1.09) |
-65.62% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
